Brain

Green Batteries Remake PTY Announces Its New Inventions That Boost Renewable Energy

Retrieved on: 
Tuesday, August 9, 2022 - 7:12am

Green Batteries Remake PTY offers a wide variety of services ranging from the recycling of household metals, and bin collection of scrap metal, to collection and transport. Recently, it introduced new inventions boosting renewable energy

Key Points: 
  • Ho Chi Minh City, Vietnam--(Newsfile Corp. - August 9, 2022) - Green Batteries Remake PTY launches new inventions boosting renewable energy.
  • Scientists in Vietnam have rolled out two renewable energy inventions that tackle the energy crisis.
  • Regarding the first research project, "the invention aims to regenerate the scrap batteries to protect the environment and save costs by reusing renewable batteries.
  • Green Batteries Remake PTY is a business division of Green Battery Remake PTY, a publicly traded company.

ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs

Retrieved on: 
Monday, August 8, 2022 - 9:05pm

Mary is a perfect example of an experienced functional leader capable of defining a Regulatory Strategy and putting the people and processes in place to execute.

Key Points: 
  • Mary is a perfect example of an experienced functional leader capable of defining a Regulatory Strategy and putting the people and processes in place to execute.
  • The Regulatory Affairs function will be one of our biggest strengths as we support our growing portfolio of pharma and device partners and our global installed base.
  • Mary is also a frequent podium speaker and panelist on a range of topics including MedTech, regulatory affairs, and women in healthcare.
  • Before joining the Company, she was Senior Vice President of Regulatory Affairs at Alira Health.

Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results

Retrieved on: 
Monday, August 8, 2022 - 9:05pm

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the second quarter ended June 30, 2022.

Key Points: 
  • Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the second quarter ended June 30, 2022.
  • In the second quarter of 2022, NUPLAZID net sales increased 17% year-over-year, said Steve Davis, Chief Executive Officer.
  • For the six months ended June 30, 2022 and 2021, Acadia reported net product sales of $250.0 million and $221.8 million, respectively.
  • For the six months ended June 30, 2022 and 2021, research and development expenses were $204.5 million and $113.9 million.

Annexon Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results

Retrieved on: 
Monday, August 8, 2022 - 9:01pm

BRISBANE, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today outlined progress across its broad pipeline of fit-for-purpose product candidates and anticipated clinical milestones, and reported second quarter 2022 financial results.

Key Points: 
  • Annexon was founded with an ambitious goal: deliver game-changing treatments to patients suffering from complement-mediated diseases by stopping the classical complement cascade at its start.
  • With the proceeds from our recent financing, we are well-positioned to execute our milestones with a multi-year runway into the second half of 2025.
  • Overall, were invigorated by the promise of our platform and pipeline to make a meaningful difference in the treatment landscape for patients.
  • Annexon is rigorously developing a pipeline of diversified product candidates across multiple mid- to late- stage clinical trials, with clinical data anticipated throughout 2022 and 2023.

Sila Realty Trust, Inc. Acquires Escondido Inpatient Rehabilitation Facility from Harrison Street for $63.4 Million

Retrieved on: 
Monday, August 8, 2022 - 6:50pm

A joint venture between Harrison Street and Pacific Medical Buildings (PMB) developed the property.

Key Points: 
  • A joint venture between Harrison Street and Pacific Medical Buildings (PMB) developed the property.
  • The Escondido IRF, known locally as the Palomar Health Rehabilitation Institute, is a two-story, build-to-suit, freestanding inpatient rehabilitation hospital located on 4.1 acres in the San Diego-Carlsbad MSA.
  • Kindred currently has 30 standalone inpatient rehabilitation facilities across 18 states.
  • We are delighted to expand our footprint in the southern California market with the acquisition of the Escondido IRF.

Vaccinex, Inc.’s Phase 2 “SIGNAL” Study to Evaluate Pepinemab Antibody in Huntington’s Disease is Published in Nature Medicine along with Detailed Mechanism of Action Study in Journal of Neuroinflammation

Retrieved on: 
Monday, August 8, 2022 - 4:00pm

ROCHESTER, N.Y., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D), today announced that results of its Phase 2 SIGNAL study to evaluate its SEMA4D-blocking antibody, pepinemab, in patients with Huntington’s Disease (HD) were published in the August 8, 2022 issue of Nature Medicine1, a leading journal for publication of translational and clinical research. In parallel, a second report has been published in the Journal of Neuroinflammation2 detailing the pathologic impact of SEMA4D on neuroinflammatory cells in both HD and Alzheimer’s disease (AD).

Key Points: 
  • These findings encourage continued development of pepinemab as a potential therapy for patients with early manifest symptoms of HD and potentially AD.
  • Accordingly, a phase 1b/2a study of pepinemab in Alzheimers disease has been initiated and is actively enrolling patients (NCT04381468).
  • The mechanism of action of pepinemab, targeting neuroinflammation2, may provide an alternative to other AD therapies that target aggregates of A amyloid.
  • The Nature Medicine publication is available online at https://www.nature.com/articles/s41591-022-01919-8 and Journal of Neuroinflammation at https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-022... ; both articles will also be posted on the Vaccinex website.

Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role

Retrieved on: 
Monday, August 8, 2022 - 3:00pm

NEW YORK, Aug. 8, 2022 /PRNewswire/ -- Peter Hoehn joins Cohen Veterans Bioscience (CVB) as Executive Vice President, Strategic Marketing, Development, and Impact.

Key Points: 
  • NEW YORK, Aug. 8, 2022 /PRNewswire/ -- Peter Hoehn joins Cohen Veterans Bioscience (CVB) as Executive Vice President, Strategic Marketing, Development, and Impact.
  • In this newly created role, Hoehn will lead the External Affairs, Communications, and Development functions for New York-based non-profit CVB which is dedicated to advancing brain health.
  • Peter Hoehn is a proven healthcare business leader with 25+ years' experience in a variety of commercial and strategy roles, predominantly at Johnson & Johnson.
  • Peter started his career as a corporate lawyer and entered the pharmaceutical industry as an attorney for Bristol Myers Squibb.

CHCI TO HONOR MUSIC LEGEND CELIA CRUZ AND SECRETARY XAVIER BECERRA AT THE 45TH ANNUAL AWARDS GALA

Retrieved on: 
Monday, August 8, 2022 - 2:00pm

"We are proud to celebrate and recognize these two trailblazers at our 45th Annual Awards Gala this year."

Key Points: 
  • "We are proud to celebrate and recognize these two trailblazers at our 45th Annual Awards Gala this year."
  • "We are thrilled to honor both Celia Cruz and Secretary Xavier Becerra at this year's gala.
  • Throughout her career, Celia Cruz redefined salsa, recording more than 80 albums and songs, earning 23 Gold Records, and winning five Grammy Awards.
  • Now, as part of Cruz's amazing musical legacy, The Celia Cruz Foundation raises funds for Hispanic students whose dream is to study music.

Balbix Announces New Integrations with ServiceNow to Further Automate and Improve Cyber Risk Quantification

Retrieved on: 
Monday, August 8, 2022 - 2:00pm

LAS VEGAS, Aug. 8, 2022 /PRNewswire/ -- Balbix, the leader in cybersecurity posture automation, announced today new integrations with ServiceNow (NYSE: NOW), the leading digital workflow company. As a result of the integrations, customers can automatically augment cyber risk data with business context and integrate remediation efforts with their existing security and IT workflows. CISOs can eliminate thousands of hours from the time required to operationalize cyber risk quantification (CRQ) in dollars and close the gap between cybersecurity and the business.

Key Points: 
  • As a result of the integrations, customers can automatically augment cyber risk data with business context and integrate remediation efforts with their existing security and IT workflows.
  • CISOs can eliminate thousands of hours from the time required to operationalize cyber risk quantification (CRQ) in dollars and close the gap between cybersecurity and the business.
  • "Our integration with the ServiceNow CMDB, has enabled us to sharply reduce the time needed to quantify cyber risk.
  • With Balbix, enterprises can automate inventory of their cloud and on-premise assets, conduct continuous risk-based vulnerability management and quantify cyber risk in dollars.

MindGift.org Founder Shares Advice for Anxiety Symptoms at National Hypnosis Conference

Retrieved on: 
Monday, August 8, 2022 - 1:53pm

DELRAY BEACH, Fla., Aug. 8, 2022 /PRNewswire/ -- There are simple ways to help countless anxiety sufferers recover from fears during the pandemic, HypnoCoach Mari Vasan advised fellow experts at "HypnoThoughts Live."

Key Points: 
  • The first group has situational or low-level anxiety, and their thoughts and behavior can shift quickly.
  • "I see midlife women who may be anxious because they believe the best part of their life is over," she said.
  • They have symptoms of anxiety, but they don't identify with it."
  • Vasan is also a member of the American Board of Hypnotherapy and the National Guild of Hypnotists.